Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Journal of Allergy and Clinical Immunology: In Practice

Published byLindsey Casey Modified over 6 years ago

Similar presentations

Presentation on theme: "The Journal of Allergy and Clinical Immunology: In Practice"— Presentation transcript:

1 The Journal of Allergy and Clinical Immunology: In Practice
Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials  Thomas B. Casale, MD, Linda S. Cox, MD, Ulrich Wahn, MD, David B.K. Golden, MD, Brigitte Bons, MD, Alain Didier, MD  The Journal of Allergy and Clinical Immunology: In Practice  DOI: /j.jaip Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Figure 1 Subject disposition. Across the development program, subjects were randomized to receive once daily either placebo or active treatment (ie, 100IR, 300IR, or 500IR 5-grass pollen extract sublingual tablet). Reasons for discontinuations were monitored. The Journal of Allergy and Clinical Immunology: In Practice DOI: ( /j.jaip ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Figure 2 Incidence of most commonly reported treatment-related AEs by time to onset in adults treated with 300IR 5-grass pollen tablet (A) and children and adolescents treated with 300IR 5-grass pollen tablet (B). The y-axis refers to the percentage of subjects with first occurrence of events. The Journal of Allergy and Clinical Immunology: In Practice DOI: ( /j.jaip ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Figure 3 Incidence of most common treatment-related AEs reported over years by time to onset in subjects included in the Long-term study. The y-axis refers to the percentage of subjects with first occurrence of events. 4M, 4-Month preseasonal treatment regimen; 2M, 2-month preseasonal treatment regimen. The Journal of Allergy and Clinical Immunology: In Practice DOI: ( /j.jaip ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Figure 4 Percentages of adults reporting treatment-related AEs according to the treatment-initiation scheme. Overall TEAEs during the first 3 days of administration (A). Most frequent TEAEs during the first 3 days with the escalation phase (B) or with direct administration (C). The Journal of Allergy and Clinical Immunology: In Practice DOI: ( /j.jaip ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "The Journal of Allergy and Clinical Immunology: In Practice"

Similar presentations

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,
Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 

Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the 2005-2006 National Health and Nutrition Examination Survey  Whitney.

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Advances in Diagnosing Peanut Allergy

Advances in Diagnosing Peanut Allergy
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses  Stephen R. Durham,

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses  Stephen R. Durham,
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,
Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.
Justin R. Chen, MD, Scott A. Tarver, PharmD, Kristin S

Justin R. Chen, MD, Scott A. Tarver, PharmD, Kristin S
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses  Stephen R. Durham,

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses  Stephen R. Durham,
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5– grass pollen tablet for seasonal allergic rhinitis  Alain Didier, MD,

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5– grass pollen tablet for seasonal allergic rhinitis  Alain Didier, MD,
Long-Term Inhaled Corticosteroid Adherence in Asthma Patients with Short-Term Adherence  Laurent Laforest, MD, PhD, Manon Belhassen, MSc, Gilles Devouassoux,

Long-Term Inhaled Corticosteroid Adherence in Asthma Patients with Short-Term Adherence  Laurent Laforest, MD, PhD, Manon Belhassen, MSc, Gilles Devouassoux,
Luciana Kase Tanno, MD, PhD, Moises A

Luciana Kase Tanno, MD, PhD, Moises A
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
Chronic rhinosinusitis: Potential new use for topical sulfasalazine

Chronic rhinosinusitis: Potential new use for topical sulfasalazine
Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:

Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:
Wells Syndrome with Bullous Lesions

Wells Syndrome with Bullous Lesions
Dennis K. Ledford, MD, Sally Wenzel, MD 

Dennis K. Ledford, MD, Sally Wenzel, MD 
Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy  Harold Nelson, MD, Shannon Cartier, MSc,

Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy  Harold Nelson, MD, Shannon Cartier, MSc,
Shyam Joshi, MD, David A. Khan, MD 

Shyam Joshi, MD, David A. Khan, MD 
Biologic Therapy and Novel Molecular Targets of Severe Asthma

Biologic Therapy and Novel Molecular Targets of Severe Asthma

Similar presentations

Ads by Google